TY - JOUR
T1 - Young-onset colorectal cancer
AU - Spaander, Manon C.W.
AU - Zauber, Ann G.
AU - Syngal, Sapna
AU - Blaser, Martin J.
AU - Sung, Joseph J.
AU - You, Y. Nancy
AU - Kuipers, Ernst J.
N1 - Funding Information:
The authors thank A. Hahn for her contribution to the article.
Publisher Copyright:
© 2023, Springer Nature Limited.
PY - 2023/4/27
Y1 - 2023/4/27
N2 - In the past decades the incidence of colorectal cancer (CRC) in people under the age of 50 years has increased, which is referred to as early-onset CRC or young-onset CRC (YO-CRC). YO-CRC is expected to account for 11% of colon cancers and 23% of rectal cancers by 2030. This trend is observed in different parts of the world and in both men and women. In 20% of patients with YO-CRC, a hereditary cancer syndrome is found as the underlying cause; however, in the majority of patients no genetic predisposition is present. Beginning in the 1950s, major changes in lifestyle such as antibiotic use, low physical activity and obesity have affected the gut microbiome and may be an important factor in YO-CRC development. Owing to a lack of screening, patients with YO-CRC are often diagnosed with advanced-stage disease. Long-term treatment-related complications should be taken into account in these younger patients, making the more traditional sequential approaches of drug therapy not always the most appropriate option. To better understand the underlying mechanism and define relationships between environmental factors and YO-CRC development, long-term prospective studies are needed with lifestyle data collected from childhood.
AB - In the past decades the incidence of colorectal cancer (CRC) in people under the age of 50 years has increased, which is referred to as early-onset CRC or young-onset CRC (YO-CRC). YO-CRC is expected to account for 11% of colon cancers and 23% of rectal cancers by 2030. This trend is observed in different parts of the world and in both men and women. In 20% of patients with YO-CRC, a hereditary cancer syndrome is found as the underlying cause; however, in the majority of patients no genetic predisposition is present. Beginning in the 1950s, major changes in lifestyle such as antibiotic use, low physical activity and obesity have affected the gut microbiome and may be an important factor in YO-CRC development. Owing to a lack of screening, patients with YO-CRC are often diagnosed with advanced-stage disease. Long-term treatment-related complications should be taken into account in these younger patients, making the more traditional sequential approaches of drug therapy not always the most appropriate option. To better understand the underlying mechanism and define relationships between environmental factors and YO-CRC development, long-term prospective studies are needed with lifestyle data collected from childhood.
UR - http://www.scopus.com/inward/record.url?scp=85157969885&partnerID=8YFLogxK
U2 - 10.1038/s41572-023-00432-7
DO - 10.1038/s41572-023-00432-7
M3 - Review article
C2 - 37105987
AN - SCOPUS:85157969885
SN - 2056-676X
VL - 9
JO - Nature Reviews Disease Primers
JF - Nature Reviews Disease Primers
IS - 21
ER -